Clinical Trials Browser

Phase 2 × Lymphoma, B-Cell, Marginal Zone × Thalidomide × Clear all

NCT03335098 2017-11-07

BOMB-THROW

Phase 2 Unknown

Waldenstrom Macroglobulinemia, Lymphoma, B-Cell, Marginal Zone

NCT00142116 2014-06-02

Thalidomide and Rituximab in Waldenstrom's Macroglobulinemia

Phase 2 Completed

25 enrolled 8 charts

Waldenstrom Macroglobulinemia, Lymphoma, B-Cell, Marginal Zone

NCT00373646 2009-06-18

Thalidomide in Mucosa Associated Lymphoid Tissue (MALT) Lymphoma Patients

Phase 2 Completed

Lymphoma, B-Cell, Marginal Zone